Comparative Pharmacology
Head-to-head clinical analysis: ANSPOR versus CEFAZOLIN AND DEXTROSE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ANSPOR versus CEFAZOLIN AND DEXTROSE.
ANSPOR vs CEFAZOLIN AND DEXTROSE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Cephalexin is a first-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death.
Bactericidal agent inhibiting bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), disrupting peptidoglycan cross-linking, leading to cell lysis. Dextrose provides osmotic diuresis and energy source.
250-500 mg orally every 6 hours for 10-14 days; maximum 4 g/day.
1-2 g IV/IM every 8 hours; maximum 12 g/day.
None Documented
None Documented
1.5–2 hours in adults with normal renal function; prolonged to 20–30 hours in severe renal impairment (CrCl <10 mL/min)
1.8 hours (prolonged to 20-40 hours in severe renal impairment, CrCl <10 mL/min)
Primarily renal (90–95%) as unchanged drug via glomerular filtration and tubular secretion; biliary excretion negligible (<1%)
Renal (80-90% unchanged via glomerular filtration and tubular secretion); biliary/fecal (<5%)
Category C
Category A/B
Cephalosporin Antibiotic
Cephalosporin Antibiotic